Joint SNMMI/NANETS Webinar: PRRT Indications Guidelines: Who to Treat
Joint SNMMI/NANETS Webinar: PRRT Indications Guidelines: Who to Treat
Joint SNMMI/NANETS PRRT Indications Guidelines:  Who to Treat
 
Fee: Complimentary

Release Date: September 5, 2019
Expiration Date: September 30, 2022

Presenters
Jonathan Strosberg, MD
Thomas Hope, MD

Financial Disclosure
In accordance with ACCME Revised Standards for Commercial Support and SNMMI Conflict-of-Interest Policy, the speaker has indicated no relevant relationships that could be perceived as a real or apparent conflict of interest. Disclosure of a relationship is not intended to suggest or to condone bias but is made to provide participants with information that might be of potential importance to their evaluation of the activity.

Target Audience
Physicians, pharmacists, and technologists

Objectives 
At the completion of this activity, the participant will be able to: 

1. Understand where 177Lutetium-dotatate might fit within the neuroendocrine tumor treatment landscape
2. Understand impact of PRRT on key endpoints including progression-free survival and health-related quality of life
3. Identify potential risks of 177Lutetium-dotatate, including long-term myelotoxicity
4. Discuss relative and absolute contraindications to treatment
Continuing Education Credit Information

Image result for ACPE logo

Pharmacist (ACPE):
The Society for Nuclear Medicine and Molecular Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity has been designated as knowledge-based CPE.  To receive CE credit, learners must first complete the activity content, achieve a score of 80% on the post-course assessment and complete the evaluation. Learners will have no more than 3 attempts to successfully complete the post-test. This activity must be completed by the expiration date listed above. The universal program number for this meeting is
0210-0000-019-956-H04-P. Total available credit for pharmacists is 1.0 hours or 0.1 CEUs.


Technologists (VOICE): 
The SNMMI, through its Verification of Involvement in Continuing Education (VOICE) program, has approved this meeting for a maximum of 1.0 continuing education hours (CEHs). VOICE-approved credit is recognized by most licensure states and by the NMTCB and ARRT as Category A+ credit. To receive CE credit, learners must first complete the activity content, achieve a score of 80% on the post-course assessment and complete the evaluation.  Learners will have no more than 3 attempts to successfully complete the post-test. This activity must be completed by the expiration date listed above. California Scope: 1.0 Therapy (T)

Minimum system requirements

Supported Internet Browsers:
- Microsoft Internet Explorer (version 7 or higher)
- Google Chrome (latest version)
- Mozilla Firefox (latest version)
- Apple Safari (version 4 or higher)

Plug-in: Adobe Acrobat Reader (http://get.adobe.com/reader/) 

For questions please contact the Education Department 703-708-9000.
© 2019 SNMMI. All rights reserved. 

For more information on our privacy policy, please click the link below. 
Type:     Internet Activity (Enduring Material)
107 Registered Users
Credits
1 Contact Hours, 0.1 CEU> Accreditation Council for Pharmacy Education> ACPE
0 Credits> Society of Nuclear Medicine and Molecular Imaging> Participation
1 CEH> Society of Nuclear Medicine and Molecular Imaging> VOICE A+